nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—stomach cancer	0.728	1	CbGaD
Trisalicylate-choline—Magnesium salicylate—PTGS2—stomach cancer	0.00132	0.365	CrCbGaD
Trisalicylate-choline—Gastric ulcer—Doxorubicin—stomach cancer	0.00127	0.00626	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Capecitabine—stomach cancer	0.00125	0.00616	CcSEcCtD
Trisalicylate-choline—Somnolence—Mitomycin—stomach cancer	0.00125	0.00616	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Docetaxel—stomach cancer	0.00124	0.00612	CcSEcCtD
Trisalicylate-choline—Burning sensation—Methotrexate—stomach cancer	0.00122	0.00604	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Floxuridine—stomach cancer	0.00122	0.00604	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Mitomycin—stomach cancer	0.00122	0.00602	CcSEcCtD
Trisalicylate-choline—Lethargy—Fluorouracil—stomach cancer	0.00121	0.00598	CcSEcCtD
Trisalicylate-choline—Hearing impaired—Capecitabine—stomach cancer	0.0012	0.00593	CcSEcCtD
Trisalicylate-choline—Pain—Mitomycin—stomach cancer	0.0012	0.00592	CcSEcCtD
Trisalicylate-choline—Magnesium salicylate—ALB—stomach cancer	0.00118	0.325	CrCbGaD
Trisalicylate-choline—Injection site reaction—Docetaxel—stomach cancer	0.00117	0.00579	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Mitomycin—stomach cancer	0.00115	0.00571	CcSEcCtD
Trisalicylate-choline—Burning sensation—Epirubicin—stomach cancer	0.00114	0.00566	CcSEcCtD
Trisalicylate-choline—Stupor—Methotrexate—stomach cancer	0.00114	0.00562	CcSEcCtD
Trisalicylate-choline—Vomiting—Floxuridine—stomach cancer	0.00113	0.00561	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Capecitabine—stomach cancer	0.00113	0.00561	CcSEcCtD
Trisalicylate-choline—Rash—Floxuridine—stomach cancer	0.00113	0.00556	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Docetaxel—stomach cancer	0.00113	0.00556	CcSEcCtD
Trisalicylate-choline—Dermatitis—Floxuridine—stomach cancer	0.00112	0.00556	CcSEcCtD
Trisalicylate-choline—Salsalate—PTGS2—stomach cancer	0.00112	0.31	CrCbGaD
Trisalicylate-choline—Headache—Floxuridine—stomach cancer	0.00112	0.00553	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Capecitabine—stomach cancer	0.0011	0.00545	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Capecitabine—stomach cancer	0.00109	0.00539	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Docetaxel—stomach cancer	0.00108	0.00532	CcSEcCtD
Trisalicylate-choline—Nausea—Floxuridine—stomach cancer	0.00106	0.00524	CcSEcCtD
Trisalicylate-choline—Burning sensation—Doxorubicin—stomach cancer	0.00106	0.00523	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Docetaxel—stomach cancer	0.00105	0.00521	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Capecitabine—stomach cancer	0.00104	0.00515	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Capecitabine—stomach cancer	0.00103	0.0051	CcSEcCtD
Trisalicylate-choline—PTGS1—blood vessel—stomach cancer	0.00101	0.113	CbGeAlD
Trisalicylate-choline—Stinging—Epirubicin—stomach cancer	0.000981	0.00485	CcSEcCtD
Trisalicylate-choline—PTGS2—blood vessel—stomach cancer	0.000962	0.108	CbGeAlD
Trisalicylate-choline—Diarrhoea—Mitomycin—stomach cancer	0.000958	0.00474	CcSEcCtD
Trisalicylate-choline—Deafness—Docetaxel—stomach cancer	0.000956	0.00473	CcSEcCtD
Trisalicylate-choline—Dizziness—Mitomycin—stomach cancer	0.000926	0.00458	CcSEcCtD
Trisalicylate-choline—Deafness—Capecitabine—stomach cancer	0.000926	0.00458	CcSEcCtD
Trisalicylate-choline—Sweating—Irinotecan—stomach cancer	0.000914	0.00452	CcSEcCtD
Trisalicylate-choline—Stinging—Doxorubicin—stomach cancer	0.000908	0.00449	CcSEcCtD
Trisalicylate-choline—PTGS2—gall bladder—stomach cancer	0.000905	0.101	CbGeAlD
Trisalicylate-choline—Vomiting—Mitomycin—stomach cancer	0.00089	0.0044	CcSEcCtD
Trisalicylate-choline—Rash—Mitomycin—stomach cancer	0.000883	0.00437	CcSEcCtD
Trisalicylate-choline—Dermatitis—Mitomycin—stomach cancer	0.000882	0.00436	CcSEcCtD
Trisalicylate-choline—Headache—Mitomycin—stomach cancer	0.000877	0.00434	CcSEcCtD
Trisalicylate-choline—Lethargy—Docetaxel—stomach cancer	0.000873	0.00432	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Epirubicin—stomach cancer	0.000868	0.00429	CcSEcCtD
Trisalicylate-choline—Epistaxis—Fluorouracil—stomach cancer	0.000861	0.00426	CcSEcCtD
Trisalicylate-choline—Lethargy—Capecitabine—stomach cancer	0.000845	0.00418	CcSEcCtD
Trisalicylate-choline—Nausea—Mitomycin—stomach cancer	0.000832	0.00411	CcSEcCtD
Trisalicylate-choline—Depressed level of consciousness—Methotrexate—stomach cancer	0.00082	0.00405	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Methotrexate—stomach cancer	0.000811	0.00401	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Doxorubicin—stomach cancer	0.000803	0.00397	CcSEcCtD
Trisalicylate-choline—Flushing—Irinotecan—stomach cancer	0.000795	0.00393	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Epirubicin—stomach cancer	0.00079	0.00391	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Docetaxel—stomach cancer	0.000781	0.00386	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Methotrexate—stomach cancer	0.000768	0.0038	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Epirubicin—stomach cancer	0.000759	0.00375	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Capecitabine—stomach cancer	0.000756	0.00374	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Doxorubicin—stomach cancer	0.000731	0.00361	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Epirubicin—stomach cancer	0.000726	0.00359	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Epirubicin—stomach cancer	0.000719	0.00355	CcSEcCtD
Trisalicylate-choline—Asthma—Capecitabine—stomach cancer	0.000716	0.00354	CcSEcCtD
Trisalicylate-choline—Erythema—Fluorouracil—stomach cancer	0.000714	0.00353	CcSEcCtD
Trisalicylate-choline—Skin exfoliation—Doxorubicin—stomach cancer	0.000702	0.00347	CcSEcCtD
Trisalicylate-choline—Abdominal discomfort—Capecitabine—stomach cancer	0.000686	0.00339	CcSEcCtD
Trisalicylate-choline—Weight increased—Docetaxel—stomach cancer	0.000673	0.00333	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Doxorubicin—stomach cancer	0.000672	0.00332	CcSEcCtD
Trisalicylate-choline—Ecchymosis—Doxorubicin—stomach cancer	0.000665	0.00329	CcSEcCtD
Trisalicylate-choline—Weight increased—Capecitabine—stomach cancer	0.000651	0.00322	CcSEcCtD
Trisalicylate-choline—Lethargy—Methotrexate—stomach cancer	0.000629	0.00311	CcSEcCtD
Trisalicylate-choline—Epistaxis—Docetaxel—stomach cancer	0.000622	0.00307	CcSEcCtD
Trisalicylate-choline—Confusional state—Irinotecan—stomach cancer	0.000613	0.00303	CcSEcCtD
Trisalicylate-choline—Oedema—Irinotecan—stomach cancer	0.000608	0.00301	CcSEcCtD
Trisalicylate-choline—Epistaxis—Capecitabine—stomach cancer	0.000602	0.00298	CcSEcCtD
Trisalicylate-choline—Shock—Irinotecan—stomach cancer	0.000598	0.00296	CcSEcCtD
Trisalicylate-choline—Hepatitis—Docetaxel—stomach cancer	0.000592	0.00293	CcSEcCtD
Trisalicylate-choline—Lethargy—Epirubicin—stomach cancer	0.000589	0.00291	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Irinotecan—stomach cancer	0.000588	0.00291	CcSEcCtD
Trisalicylate-choline—Confusional state—Fluorouracil—stomach cancer	0.000587	0.0029	CcSEcCtD
Trisalicylate-choline—Oedema—Fluorouracil—stomach cancer	0.000583	0.00288	CcSEcCtD
Trisalicylate-choline—Anorexia—Irinotecan—stomach cancer	0.00058	0.00287	CcSEcCtD
Trisalicylate-choline—Hepatitis—Capecitabine—stomach cancer	0.000573	0.00283	CcSEcCtD
Trisalicylate-choline—Hypotension—Irinotecan—stomach cancer	0.000568	0.00281	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Docetaxel—stomach cancer	0.00056	0.00277	CcSEcCtD
Trisalicylate-choline—Anorexia—Fluorouracil—stomach cancer	0.000555	0.00275	CcSEcCtD
Trisalicylate-choline—Flushing—Docetaxel—stomach cancer	0.000549	0.00272	CcSEcCtD
Trisalicylate-choline—Lethargy—Doxorubicin—stomach cancer	0.000545	0.00269	CcSEcCtD
Trisalicylate-choline—Hypotension—Fluorouracil—stomach cancer	0.000544	0.00269	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Capecitabine—stomach cancer	0.000542	0.00268	CcSEcCtD
Trisalicylate-choline—Somnolence—Irinotecan—stomach cancer	0.000541	0.00267	CcSEcCtD
Trisalicylate-choline—PTGS1—hematopoietic system—stomach cancer	0.000536	0.0601	CbGeAlD
Trisalicylate-choline—Dyspepsia—Irinotecan—stomach cancer	0.000535	0.00265	CcSEcCtD
Trisalicylate-choline—Tinnitus—Capecitabine—stomach cancer	0.000534	0.00264	CcSEcCtD
Trisalicylate-choline—Asthma—Methotrexate—stomach cancer	0.000533	0.00263	CcSEcCtD
Trisalicylate-choline—Flushing—Capecitabine—stomach cancer	0.000532	0.00263	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Irinotecan—stomach cancer	0.000529	0.00261	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Epirubicin—stomach cancer	0.000527	0.00261	CcSEcCtD
Trisalicylate-choline—Pain—Irinotecan—stomach cancer	0.00052	0.00257	CcSEcCtD
Trisalicylate-choline—Constipation—Irinotecan—stomach cancer	0.00052	0.00257	CcSEcCtD
Trisalicylate-choline—Somnolence—Fluorouracil—stomach cancer	0.000518	0.00256	CcSEcCtD
Trisalicylate-choline—Erythema—Docetaxel—stomach cancer	0.000515	0.00255	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Fluorouracil—stomach cancer	0.000513	0.00254	CcSEcCtD
Trisalicylate-choline—PTGS2—hematopoietic system—stomach cancer	0.000512	0.0574	CbGeAlD
Trisalicylate-choline—Abdominal discomfort—Methotrexate—stomach cancer	0.000511	0.00253	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Fluorouracil—stomach cancer	0.000506	0.0025	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Docetaxel—stomach cancer	0.000504	0.00249	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Irinotecan—stomach cancer	0.000501	0.00248	CcSEcCtD
Trisalicylate-choline—Erythema—Capecitabine—stomach cancer	0.000499	0.00247	CcSEcCtD
Trisalicylate-choline—Asthma—Epirubicin—stomach cancer	0.000499	0.00247	CcSEcCtD
Trisalicylate-choline—Pain—Fluorouracil—stomach cancer	0.000498	0.00246	CcSEcCtD
Trisalicylate-choline—PTGS1—epithelium—stomach cancer	0.00049	0.0549	CbGeAlD
Trisalicylate-choline—Dysgeusia—Capecitabine—stomach cancer	0.000488	0.00241	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Doxorubicin—stomach cancer	0.000488	0.00241	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Fluorouracil—stomach cancer	0.00048	0.00237	CcSEcCtD
Trisalicylate-choline—Drowsiness—Methotrexate—stomach cancer	0.000475	0.00235	CcSEcCtD
Trisalicylate-choline—PTGS1—smooth muscle tissue—stomach cancer	0.000472	0.0529	CbGeAlD
Trisalicylate-choline—PTGS2—epithelium—stomach cancer	0.000468	0.0525	CbGeAlD
Trisalicylate-choline—Urticaria—Fluorouracil—stomach cancer	0.000463	0.00229	CcSEcCtD
Trisalicylate-choline—Asthma—Doxorubicin—stomach cancer	0.000461	0.00228	CcSEcCtD
Trisalicylate-choline—Sweating—Methotrexate—stomach cancer	0.000455	0.00225	CcSEcCtD
Trisalicylate-choline—Weight increased—Epirubicin—stomach cancer	0.000454	0.00224	CcSEcCtD
Trisalicylate-choline—PTGS2—smooth muscle tissue—stomach cancer	0.000451	0.0506	CbGeAlD
Trisalicylate-choline—Epistaxis—Methotrexate—stomach cancer	0.000448	0.00222	CcSEcCtD
Trisalicylate-choline—Drowsiness—Epirubicin—stomach cancer	0.000445	0.0022	CcSEcCtD
Trisalicylate-choline—Hepatitis—Methotrexate—stomach cancer	0.000427	0.00211	CcSEcCtD
Trisalicylate-choline—Sweating—Epirubicin—stomach cancer	0.000426	0.00211	CcSEcCtD
Trisalicylate-choline—Confusional state—Docetaxel—stomach cancer	0.000424	0.0021	CcSEcCtD
Trisalicylate-choline—Oedema—Docetaxel—stomach cancer	0.00042	0.00208	CcSEcCtD
Trisalicylate-choline—Weight increased—Doxorubicin—stomach cancer	0.00042	0.00208	CcSEcCtD
Trisalicylate-choline—Epistaxis—Epirubicin—stomach cancer	0.000419	0.00207	CcSEcCtD
Trisalicylate-choline—PTGS2—pancreas—stomach cancer	0.000417	0.0467	CbGeAlD
Trisalicylate-choline—Diarrhoea—Irinotecan—stomach cancer	0.000416	0.00206	CcSEcCtD
Trisalicylate-choline—Shock—Docetaxel—stomach cancer	0.000414	0.00205	CcSEcCtD
Trisalicylate-choline—Pruritus—Fluorouracil—stomach cancer	0.000412	0.00204	CcSEcCtD
Trisalicylate-choline—Drowsiness—Doxorubicin—stomach cancer	0.000411	0.00203	CcSEcCtD
Trisalicylate-choline—Confusional state—Capecitabine—stomach cancer	0.00041	0.00203	CcSEcCtD
Trisalicylate-choline—Oedema—Capecitabine—stomach cancer	0.000407	0.00201	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Methotrexate—stomach cancer	0.000403	0.00199	CcSEcCtD
Trisalicylate-choline—Dizziness—Irinotecan—stomach cancer	0.000402	0.00199	CcSEcCtD
Trisalicylate-choline—Anorexia—Docetaxel—stomach cancer	0.000401	0.00198	CcSEcCtD
Trisalicylate-choline—Shock—Capecitabine—stomach cancer	0.0004	0.00198	CcSEcCtD
Trisalicylate-choline—Hepatitis—Epirubicin—stomach cancer	0.000399	0.00197	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Fluorouracil—stomach cancer	0.000399	0.00197	CcSEcCtD
Trisalicylate-choline—Tinnitus—Methotrexate—stomach cancer	0.000398	0.00197	CcSEcCtD
Trisalicylate-choline—Sweating—Doxorubicin—stomach cancer	0.000394	0.00195	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Capecitabine—stomach cancer	0.000394	0.00195	CcSEcCtD
Trisalicylate-choline—Hypotension—Docetaxel—stomach cancer	0.000393	0.00194	CcSEcCtD
Trisalicylate-choline—Epistaxis—Doxorubicin—stomach cancer	0.000388	0.00192	CcSEcCtD
Trisalicylate-choline—Anorexia—Capecitabine—stomach cancer	0.000388	0.00192	CcSEcCtD
Trisalicylate-choline—Vomiting—Irinotecan—stomach cancer	0.000387	0.00191	CcSEcCtD
Trisalicylate-choline—Dizziness—Fluorouracil—stomach cancer	0.000385	0.0019	CcSEcCtD
Trisalicylate-choline—Rash—Irinotecan—stomach cancer	0.000383	0.0019	CcSEcCtD
Trisalicylate-choline—Dermatitis—Irinotecan—stomach cancer	0.000383	0.00189	CcSEcCtD
Trisalicylate-choline—Headache—Irinotecan—stomach cancer	0.000381	0.00188	CcSEcCtD
Trisalicylate-choline—Hypotension—Capecitabine—stomach cancer	0.00038	0.00188	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Epirubicin—stomach cancer	0.000377	0.00187	CcSEcCtD
Trisalicylate-choline—Somnolence—Docetaxel—stomach cancer	0.000374	0.00185	CcSEcCtD
Trisalicylate-choline—PTGS1—digestive system—stomach cancer	0.000373	0.0418	CbGeAlD
Trisalicylate-choline—Tinnitus—Epirubicin—stomach cancer	0.000372	0.00184	CcSEcCtD
Trisalicylate-choline—Erythema—Methotrexate—stomach cancer	0.000371	0.00184	CcSEcCtD
Trisalicylate-choline—Flushing—Epirubicin—stomach cancer	0.00037	0.00183	CcSEcCtD
Trisalicylate-choline—Vomiting—Fluorouracil—stomach cancer	0.00037	0.00183	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Docetaxel—stomach cancer	0.00037	0.00183	CcSEcCtD
Trisalicylate-choline—Hepatitis—Doxorubicin—stomach cancer	0.000369	0.00183	CcSEcCtD
Trisalicylate-choline—Rash—Fluorouracil—stomach cancer	0.000367	0.00182	CcSEcCtD
Trisalicylate-choline—Dermatitis—Fluorouracil—stomach cancer	0.000367	0.00181	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Docetaxel—stomach cancer	0.000365	0.00181	CcSEcCtD
Trisalicylate-choline—Headache—Fluorouracil—stomach cancer	0.000365	0.0018	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Methotrexate—stomach cancer	0.000364	0.0018	CcSEcCtD
Trisalicylate-choline—Nausea—Irinotecan—stomach cancer	0.000361	0.00179	CcSEcCtD
Trisalicylate-choline—PTGS2—lymphoid tissue—stomach cancer	0.000361	0.0404	CbGeAlD
Trisalicylate-choline—Constipation—Docetaxel—stomach cancer	0.00036	0.00178	CcSEcCtD
Trisalicylate-choline—Pain—Docetaxel—stomach cancer	0.00036	0.00178	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Capecitabine—stomach cancer	0.000358	0.00177	CcSEcCtD
Trisalicylate-choline—PTGS2—digestive system—stomach cancer	0.000356	0.0399	CbGeAlD
Trisalicylate-choline—Decreased appetite—Capecitabine—stomach cancer	0.000354	0.00175	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Doxorubicin—stomach cancer	0.000349	0.00173	CcSEcCtD
Trisalicylate-choline—Pain—Capecitabine—stomach cancer	0.000348	0.00172	CcSEcCtD
Trisalicylate-choline—Constipation—Capecitabine—stomach cancer	0.000348	0.00172	CcSEcCtD
Trisalicylate-choline—Erythema—Epirubicin—stomach cancer	0.000347	0.00172	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Docetaxel—stomach cancer	0.000346	0.00171	CcSEcCtD
Trisalicylate-choline—Nausea—Fluorouracil—stomach cancer	0.000346	0.00171	CcSEcCtD
Trisalicylate-choline—Tinnitus—Doxorubicin—stomach cancer	0.000344	0.0017	CcSEcCtD
Trisalicylate-choline—Flushing—Doxorubicin—stomach cancer	0.000343	0.00169	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Epirubicin—stomach cancer	0.00034	0.00168	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Capecitabine—stomach cancer	0.000335	0.00166	CcSEcCtD
Trisalicylate-choline—PTGS2—bone marrow—stomach cancer	0.000328	0.0368	CbGeAlD
Trisalicylate-choline—Urticaria—Capecitabine—stomach cancer	0.000323	0.0016	CcSEcCtD
Trisalicylate-choline—Erythema—Doxorubicin—stomach cancer	0.000322	0.00159	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Doxorubicin—stomach cancer	0.000315	0.00156	CcSEcCtD
Trisalicylate-choline—PTGS1—endocrine gland—stomach cancer	0.000308	0.0345	CbGeAlD
Trisalicylate-choline—Confusional state—Methotrexate—stomach cancer	0.000306	0.00151	CcSEcCtD
Trisalicylate-choline—Pruritus—Docetaxel—stomach cancer	0.000297	0.00147	CcSEcCtD
Trisalicylate-choline—PTGS2—endocrine gland—stomach cancer	0.000294	0.033	CbGeAlD
Trisalicylate-choline—Hyperhidrosis—Methotrexate—stomach cancer	0.000293	0.00145	CcSEcCtD
Trisalicylate-choline—Anorexia—Methotrexate—stomach cancer	0.000289	0.00143	CcSEcCtD
Trisalicylate-choline—Pruritus—Capecitabine—stomach cancer	0.000288	0.00142	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Docetaxel—stomach cancer	0.000288	0.00142	CcSEcCtD
Trisalicylate-choline—Confusional state—Epirubicin—stomach cancer	0.000286	0.00141	CcSEcCtD
Trisalicylate-choline—Oedema—Epirubicin—stomach cancer	0.000284	0.0014	CcSEcCtD
Trisalicylate-choline—Hypotension—Methotrexate—stomach cancer	0.000283	0.0014	CcSEcCtD
Trisalicylate-choline—Shock—Epirubicin—stomach cancer	0.000279	0.00138	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Capecitabine—stomach cancer	0.000279	0.00138	CcSEcCtD
Trisalicylate-choline—Dizziness—Docetaxel—stomach cancer	0.000278	0.00137	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Epirubicin—stomach cancer	0.000274	0.00136	CcSEcCtD
Trisalicylate-choline—Anorexia—Epirubicin—stomach cancer	0.00027	0.00134	CcSEcCtD
Trisalicylate-choline—Somnolence—Methotrexate—stomach cancer	0.000269	0.00133	CcSEcCtD
Trisalicylate-choline—Dizziness—Capecitabine—stomach cancer	0.000269	0.00133	CcSEcCtD
Trisalicylate-choline—Vomiting—Docetaxel—stomach cancer	0.000267	0.00132	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Methotrexate—stomach cancer	0.000267	0.00132	CcSEcCtD
Trisalicylate-choline—PTGS2—liver—stomach cancer	0.000265	0.0297	CbGeAlD
Trisalicylate-choline—Rash—Docetaxel—stomach cancer	0.000265	0.00131	CcSEcCtD
Trisalicylate-choline—Hypotension—Epirubicin—stomach cancer	0.000265	0.00131	CcSEcCtD
Trisalicylate-choline—Dermatitis—Docetaxel—stomach cancer	0.000265	0.00131	CcSEcCtD
Trisalicylate-choline—Confusional state—Doxorubicin—stomach cancer	0.000265	0.00131	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Methotrexate—stomach cancer	0.000263	0.0013	CcSEcCtD
Trisalicylate-choline—Headache—Docetaxel—stomach cancer	0.000263	0.0013	CcSEcCtD
Trisalicylate-choline—Oedema—Doxorubicin—stomach cancer	0.000262	0.0013	CcSEcCtD
Trisalicylate-choline—Pain—Methotrexate—stomach cancer	0.000259	0.00128	CcSEcCtD
Trisalicylate-choline—Vomiting—Capecitabine—stomach cancer	0.000259	0.00128	CcSEcCtD
Trisalicylate-choline—Shock—Doxorubicin—stomach cancer	0.000258	0.00128	CcSEcCtD
Trisalicylate-choline—Rash—Capecitabine—stomach cancer	0.000257	0.00127	CcSEcCtD
Trisalicylate-choline—Dermatitis—Capecitabine—stomach cancer	0.000256	0.00127	CcSEcCtD
Trisalicylate-choline—Headache—Capecitabine—stomach cancer	0.000255	0.00126	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Doxorubicin—stomach cancer	0.000254	0.00125	CcSEcCtD
Trisalicylate-choline—Somnolence—Epirubicin—stomach cancer	0.000252	0.00125	CcSEcCtD
Trisalicylate-choline—Anorexia—Doxorubicin—stomach cancer	0.00025	0.00124	CcSEcCtD
Trisalicylate-choline—Nausea—Docetaxel—stomach cancer	0.00025	0.00123	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Methotrexate—stomach cancer	0.00025	0.00123	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Epirubicin—stomach cancer	0.00025	0.00123	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Epirubicin—stomach cancer	0.000247	0.00122	CcSEcCtD
Trisalicylate-choline—Hypotension—Doxorubicin—stomach cancer	0.000245	0.00121	CcSEcCtD
Trisalicylate-choline—Pain—Epirubicin—stomach cancer	0.000243	0.0012	CcSEcCtD
Trisalicylate-choline—Constipation—Epirubicin—stomach cancer	0.000243	0.0012	CcSEcCtD
Trisalicylate-choline—Nausea—Capecitabine—stomach cancer	0.000242	0.0012	CcSEcCtD
Trisalicylate-choline—Urticaria—Methotrexate—stomach cancer	0.000241	0.00119	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Epirubicin—stomach cancer	0.000234	0.00116	CcSEcCtD
Trisalicylate-choline—Somnolence—Doxorubicin—stomach cancer	0.000233	0.00115	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Doxorubicin—stomach cancer	0.000231	0.00114	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Doxorubicin—stomach cancer	0.000228	0.00113	CcSEcCtD
Trisalicylate-choline—Urticaria—Epirubicin—stomach cancer	0.000225	0.00111	CcSEcCtD
Trisalicylate-choline—Pain—Doxorubicin—stomach cancer	0.000224	0.00111	CcSEcCtD
Trisalicylate-choline—Constipation—Doxorubicin—stomach cancer	0.000224	0.00111	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Doxorubicin—stomach cancer	0.000216	0.00107	CcSEcCtD
Trisalicylate-choline—Pruritus—Methotrexate—stomach cancer	0.000214	0.00106	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SOD2—stomach cancer	0.000213	0.00373	CbGpPWpGaD
Trisalicylate-choline—PTGS1—lymph node—stomach cancer	0.000213	0.0239	CbGeAlD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000212	0.00371	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000212	0.0037	CbGpPWpGaD
Trisalicylate-choline—Urticaria—Doxorubicin—stomach cancer	0.000208	0.00103	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Methotrexate—stomach cancer	0.000207	0.00103	CcSEcCtD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—APEX1—stomach cancer	0.000205	0.00358	CbGpPWpGaD
Trisalicylate-choline—PTGS2—lymph node—stomach cancer	0.000203	0.0228	CbGeAlD
Trisalicylate-choline—Pruritus—Epirubicin—stomach cancer	0.000201	0.000992	CcSEcCtD
Trisalicylate-choline—Dizziness—Methotrexate—stomach cancer	0.0002	0.000991	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Epirubicin—stomach cancer	0.000194	0.000959	CcSEcCtD
Trisalicylate-choline—Vomiting—Methotrexate—stomach cancer	0.000193	0.000953	CcSEcCtD
Trisalicylate-choline—Rash—Methotrexate—stomach cancer	0.000191	0.000945	CcSEcCtD
Trisalicylate-choline—Dermatitis—Methotrexate—stomach cancer	0.000191	0.000944	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.00019	0.00333	CbGpPWpGaD
Trisalicylate-choline—Headache—Methotrexate—stomach cancer	0.00019	0.000939	CcSEcCtD
Trisalicylate-choline—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—stomach cancer	0.000189	0.00332	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—MTHFR—stomach cancer	0.000188	0.00329	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Epirubicin—stomach cancer	0.000188	0.000927	CcSEcCtD
Trisalicylate-choline—Pruritus—Doxorubicin—stomach cancer	0.000186	0.000918	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000184	0.00322	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—stomach cancer	0.000182	0.00319	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Epirubicin—stomach cancer	0.00018	0.000891	CcSEcCtD
Trisalicylate-choline—Nausea—Methotrexate—stomach cancer	0.00018	0.00089	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Doxorubicin—stomach cancer	0.00018	0.000888	CcSEcCtD
Trisalicylate-choline—Rash—Epirubicin—stomach cancer	0.000179	0.000884	CcSEcCtD
Trisalicylate-choline—Dermatitis—Epirubicin—stomach cancer	0.000179	0.000883	CcSEcCtD
Trisalicylate-choline—Headache—Epirubicin—stomach cancer	0.000178	0.000878	CcSEcCtD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000178	0.00311	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—BDNF—stomach cancer	0.000176	0.00308	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000176	0.00308	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Doxorubicin—stomach cancer	0.000174	0.000858	CcSEcCtD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—APOA1—stomach cancer	0.000173	0.00302	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000173	0.00302	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—ALB—stomach cancer	0.000172	0.00302	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTP1—stomach cancer	0.00017	0.00298	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—stomach cancer	0.00017	0.00297	CbGpPWpGaD
Trisalicylate-choline—Nausea—Epirubicin—stomach cancer	0.000168	0.000833	CcSEcCtD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000168	0.00294	CbGpPWpGaD
Trisalicylate-choline—Vomiting—Doxorubicin—stomach cancer	0.000167	0.000825	CcSEcCtD
Trisalicylate-choline—Rash—Doxorubicin—stomach cancer	0.000165	0.000818	CcSEcCtD
Trisalicylate-choline—Dermatitis—Doxorubicin—stomach cancer	0.000165	0.000817	CcSEcCtD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000165	0.00288	CbGpPWpGaD
Trisalicylate-choline—Headache—Doxorubicin—stomach cancer	0.000164	0.000813	CcSEcCtD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.000158	0.00277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000157	0.00275	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—GSTM1—stomach cancer	0.000156	0.00274	CbGpPWpGaD
Trisalicylate-choline—Nausea—Doxorubicin—stomach cancer	0.000156	0.000771	CcSEcCtD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—stomach cancer	0.000151	0.00264	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—stomach cancer	0.000149	0.00261	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ACAD8—stomach cancer	0.000146	0.00256	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000146	0.00255	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000143	0.00251	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000143	0.0025	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000143	0.0025	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000143	0.0025	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000141	0.00247	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL1B—stomach cancer	0.00014	0.00246	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—SERPINE1—stomach cancer	0.000137	0.0024	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—ALB—stomach cancer	0.000137	0.0024	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000136	0.00238	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000135	0.00236	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000135	0.00235	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN2A—stomach cancer	0.000133	0.00233	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDK4—stomach cancer	0.000132	0.00232	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GMPR2—stomach cancer	0.00013	0.00228	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—stomach cancer	0.000127	0.00222	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000126	0.00221	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000124	0.00218	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.00012	0.00209	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—IDH3B—stomach cancer	0.000119	0.00209	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SUCLG1—stomach cancer	0.000119	0.00209	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1B—stomach cancer	0.000118	0.00206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000118	0.00206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ACAD8—stomach cancer	0.000116	0.00203	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000116	0.00202	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000114	0.002	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000114	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CCND1—stomach cancer	0.000112	0.00197	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL1B—stomach cancer	0.000111	0.00195	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NDUFV1—stomach cancer	0.000111	0.00194	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NDUFS1—stomach cancer	0.000111	0.00194	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN1A—stomach cancer	0.000109	0.0019	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000108	0.0019	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000107	0.00187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—RHOA—stomach cancer	0.000105	0.00183	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GMPR2—stomach cancer	0.000104	0.00181	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—TNF—stomach cancer	0.000102	0.00178	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.0001	0.00175	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PGLS—stomach cancer	9.89e-05	0.00173	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—BLVRB—stomach cancer	9.89e-05	0.00173	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	9.88e-05	0.00173	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—IDH3B—stomach cancer	9.47e-05	0.00166	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SUCLG1—stomach cancer	9.47e-05	0.00166	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPAP2A—stomach cancer	9.43e-05	0.00165	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PGLS—stomach cancer	9.37e-05	0.00164	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—stomach cancer	9.18e-05	0.00161	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	9.07e-05	0.00159	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	9.01e-05	0.00158	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—MYC—stomach cancer	9e-05	0.00158	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	8.97e-05	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RBP1—stomach cancer	8.94e-05	0.00157	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	8.81e-05	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NDUFV1—stomach cancer	8.81e-05	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NDUFS1—stomach cancer	8.81e-05	0.00154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	8.61e-05	0.00151	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	8.55e-05	0.0015	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	8.48e-05	0.00148	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CKB—stomach cancer	8.41e-05	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA1—stomach cancer	8.41e-05	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NDUFA2—stomach cancer	8.41e-05	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FBP1—stomach cancer	8.41e-05	0.00147	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	8.32e-05	0.00146	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	8.3e-05	0.00145	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—IL6—stomach cancer	8.21e-05	0.00144	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	8.08e-05	0.00141	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FBP1—stomach cancer	7.97e-05	0.0014	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLIN2—stomach cancer	7.9e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	7.9e-05	0.00138	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—BLVRB—stomach cancer	7.85e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PGLS—stomach cancer	7.85e-05	0.00137	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CA2—stomach cancer	7.69e-05	0.00135	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PGAM1—stomach cancer	7.49e-05	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NT5E—stomach cancer	7.49e-05	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPAP2A—stomach cancer	7.49e-05	0.00131	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.2e-05	0.00126	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDH7A1—stomach cancer	7.15e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PLCE1—stomach cancer	7.15e-05	0.00125	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PGAM1—stomach cancer	7.1e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	7.07e-05	0.00124	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	7.05e-05	0.00123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MYC—stomach cancer	6.86e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—UMPS—stomach cancer	6.85e-05	0.0012	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—WIF1—stomach cancer	6.78e-05	0.00119	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	6.71e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	6.71e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FBP1—stomach cancer	6.67e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NDUFA2—stomach cancer	6.67e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CKB—stomach cancer	6.67e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA1—stomach cancer	6.67e-05	0.00117	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.59e-05	0.00115	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	6.52e-05	0.00114	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TNF—stomach cancer	6.39e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PDHA1—stomach cancer	6.37e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ECHS1—stomach cancer	6.37e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL18—stomach cancer	6.37e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL13—stomach cancer	6.37e-05	0.00112	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLIN2—stomach cancer	6.28e-05	0.0011	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CA2—stomach cancer	6.1e-05	0.00107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	6.1e-05	0.00107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RNF43—stomach cancer	6.04e-05	0.00106	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TYMP—stomach cancer	5.99e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—FADS1—stomach cancer	5.99e-05	0.00105	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PGAM1—stomach cancer	5.95e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NT5E—stomach cancer	5.95e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS21—stomach cancer	5.94e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS15—stomach cancer	5.94e-05	0.00104	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.82e-05	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.81e-05	0.00102	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDH7A1—stomach cancer	5.68e-05	0.000994	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PLCE1—stomach cancer	5.68e-05	0.000994	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—stomach cancer	5.63e-05	0.000986	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.63e-05	0.000985	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SREBF2—stomach cancer	5.61e-05	0.000982	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—RORA—stomach cancer	5.54e-05	0.00097	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.49e-05	0.000962	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—UMPS—stomach cancer	5.44e-05	0.000953	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALDOB—stomach cancer	5.19e-05	0.000909	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—IL6—stomach cancer	5.16e-05	0.000903	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	5.07e-05	0.000888	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PDHA1—stomach cancer	5.06e-05	0.000886	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ECHS1—stomach cancer	5.06e-05	0.000886	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ALDOB—stomach cancer	4.92e-05	0.000862	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.9e-05	0.000857	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.89e-05	0.000856	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALOX5—stomach cancer	4.83e-05	0.000845	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPL15—stomach cancer	4.83e-05	0.000845	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.8e-05	0.00084	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—FADS1—stomach cancer	4.76e-05	0.000833	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TYMP—stomach cancer	4.76e-05	0.000833	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—DPYD—stomach cancer	4.75e-05	0.000832	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NPM1—stomach cancer	4.74e-05	0.00083	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.67e-05	0.000817	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RBP4—stomach cancer	4.58e-05	0.000801	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.57e-05	0.000799	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.56e-05	0.000799	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS26—stomach cancer	4.5e-05	0.000788	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPIA—stomach cancer	4.47e-05	0.000782	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SREBF2—stomach cancer	4.45e-05	0.00078	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—RORA—stomach cancer	4.4e-05	0.00077	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.35e-05	0.000761	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.31e-05	0.000755	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.31e-05	0.000754	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTT1—stomach cancer	4.2e-05	0.000735	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP2A6—stomach cancer	4.15e-05	0.000727	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALDOB—stomach cancer	4.12e-05	0.000722	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—AKR1C3—stomach cancer	4.04e-05	0.000707	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.96e-05	0.000694	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ENO1—stomach cancer	3.94e-05	0.000689	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.89e-05	0.000681	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.88e-05	0.000679	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.87e-05	0.000678	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALOX5—stomach cancer	3.83e-05	0.000671	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.83e-05	0.000671	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—AKR1C3—stomach cancer	3.83e-05	0.00067	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS19—stomach cancer	3.83e-05	0.00067	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—DPYD—stomach cancer	3.77e-05	0.00066	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ENO1—stomach cancer	3.73e-05	0.000653	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CD44—stomach cancer	3.49e-05	0.000611	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.42e-05	0.000598	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.39e-05	0.000593	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RPS6—stomach cancer	3.39e-05	0.000593	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTT1—stomach cancer	3.33e-05	0.000584	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CD44—stomach cancer	3.31e-05	0.000579	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP2A6—stomach cancer	3.3e-05	0.000577	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—AKR1C3—stomach cancer	3.21e-05	0.000561	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ENO1—stomach cancer	3.13e-05	0.000547	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HBEGF—stomach cancer	3.11e-05	0.000545	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.07e-05	0.000538	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPP2R1A—stomach cancer	2.97e-05	0.00052	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTP1—stomach cancer	2.91e-05	0.00051	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—HMOX1—stomach cancer	2.87e-05	0.000503	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PPP2R1A—stomach cancer	2.81e-05	0.000493	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CD44—stomach cancer	2.77e-05	0.000485	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—TYMS—stomach cancer	2.71e-05	0.000474	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—GSTM1—stomach cancer	2.68e-05	0.000468	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SMAD4—stomach cancer	2.61e-05	0.000457	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ERCC2—stomach cancer	2.52e-05	0.00044	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FYN—stomach cancer	2.48e-05	0.000434	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERCC2—stomach cancer	2.38e-05	0.000417	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—MTHFR—stomach cancer	2.36e-05	0.000414	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPP2R1A—stomach cancer	2.36e-05	0.000413	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—FGFR2—stomach cancer	2.33e-05	0.000408	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTP1—stomach cancer	2.31e-05	0.000405	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—HMOX1—stomach cancer	2.28e-05	0.000399	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MTHFR—stomach cancer	2.24e-05	0.000392	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CAV1—stomach cancer	2.18e-05	0.000382	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—APOA1—stomach cancer	2.18e-05	0.000381	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—TYMS—stomach cancer	2.15e-05	0.000376	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IRS2—stomach cancer	2.13e-05	0.000373	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—GSTM1—stomach cancer	2.12e-05	0.000372	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.08e-05	0.000365	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CAV1—stomach cancer	2.07e-05	0.000362	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APOA1—stomach cancer	2.06e-05	0.000361	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ERCC2—stomach cancer	2e-05	0.00035	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6ST—stomach cancer	1.96e-05	0.000343	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—stomach cancer	1.92e-05	0.000336	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APC—stomach cancer	1.88e-05	0.00033	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—MTHFR—stomach cancer	1.88e-05	0.000329	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6R—stomach cancer	1.75e-05	0.000306	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CAV1—stomach cancer	1.73e-05	0.000303	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—APOA1—stomach cancer	1.73e-05	0.000302	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—ALB—stomach cancer	1.72e-05	0.000302	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.65e-05	0.00029	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—NOS3—stomach cancer	1.65e-05	0.000289	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SERPINE1—stomach cancer	1.64e-05	0.000287	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—RHOA—stomach cancer	1.58e-05	0.000277	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—NOS3—stomach cancer	1.56e-05	0.000274	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—stomach cancer	1.52e-05	0.000267	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—stomach cancer	1.51e-05	0.000264	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—ERBB2—stomach cancer	1.46e-05	0.000256	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—ALB—stomach cancer	1.37e-05	0.00024	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1B—stomach cancer	1.35e-05	0.000237	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—NOS3—stomach cancer	1.31e-05	0.000229	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—CDKN1A—stomach cancer	1.25e-05	0.000219	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—STAT3—stomach cancer	1.12e-05	0.000195	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK3—stomach cancer	1.07e-05	0.000187	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MYC—stomach cancer	1.04e-05	0.000181	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—MAPK1—stomach cancer	1.01e-05	0.000177	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—EGFR—stomach cancer	1.01e-05	0.000177	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—KRAS—stomach cancer	9.58e-06	0.000168	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PIK3CA—stomach cancer	9.28e-06	0.000162	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—PIK3CA—stomach cancer	8.8e-06	0.000154	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—HRAS—stomach cancer	8.14e-06	0.000142	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—IL6—stomach cancer	7.79e-06	0.000136	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PIK3CA—stomach cancer	7.37e-06	0.000129	CbGpPWpGaD
